Optiver Holding’s CervoMed CRVO Stock Holding History

Optiver Holding’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10	Closed	-$39	–	2827
2026 Q1	$39	Hold	10	–	–	﹤0.01%	2263
2025 Q4	$79	Hold	10	–	–	﹤0.01%	2379
2025 Q3	$81	Buy	+10	New	+$86	﹤0.01%	2602

Other funds holding CRVO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

Optiver Holding's CRVO Position: Q2 2026 in Review

Optiver Holding sold out of CervoMed (CRVO) in Q2 2026, closing a stake of 10 shares — an estimated $39 sold.

Optiver Holding first reported a position in CRVO in Q3 2025 and held it in 3 quarters. The position peaked at $81 in Q3 2025. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

Optiver Holding reported no remaining CervoMed position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 10 CervoMed shares in Q2 2026, an estimated $39.
Optiver Holding first reported a position in CervoMed in Q3 2025 and held it in 3 quarters.
Optiver Holding's CervoMed position peaked at $81 in Q3 2025.
37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.